Capital International, Inc. Abb Vie Inc. Transaction History

Capital International, Inc.

$7.23 Billion
Q2 2024

A detailed history of Capital International, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Capital International, Inc. holds 409,891 shares of ABBV stock, worth $82.7 Million. This represents 0.97% of its overall portfolio holdings.

Number of Shares

409,891

Previous 385,832 6.24%

Holding current value

$82.7 Million

Previous $70.3 Million 0.06%

% of portfolio

0.97%

Previous 0.99%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$154.79 - $180.76 $3.72 Million - $4.35 Million	24,059 Added 6.24%	409,891 $70.3 Million
Q1 2024 May 14, 2024	BUY	$159.82 - $182.1 $13.9 Million - $15.9 Million	87,180 Added 29.19%	385,832 $70.3 Million
Q4 2023 Feb 13, 2024	BUY	$137.6 - $154.97 $9.45 Million - $10.6 Million	68,663 Added 29.85%	298,652 $46.3 Million
Q3 2023 Nov 13, 2023	BUY	$133.59 - $154.65 $5.23 Million - $6.05 Million	39,139 Added 20.51%	229,989 $34.3 Million
Q2 2023 Aug 11, 2023	BUY	$132.51 - $164.9 $19.3 Million - $24.1 Million	145,858 Added 324.19%	190,850 $25.7 Million
Q1 2023 May 15, 2023	SELL	$144.61 - $166.54 $1.13 Million - $1.31 Million	-7,838 Reduced 14.84%	44,992 $7.17 Million
Q4 2022 Feb 14, 2023	BUY	$138.31 - $165.87 $327,241 - $392,448	2,366 Added 4.69%	52,830 $8.54 Million
Q3 2022 Nov 14, 2022	SELL	$134.21 - $153.93 $265,735 - $304,781	-1,980 Reduced 3.78%	50,464 $6.77 Million
Q2 2022 Aug 15, 2022	BUY	$137.62 - $174.96 $3.5 Million - $4.45 Million	25,446 Added 94.25%	52,444 $8.03 Million
Q1 2022 May 16, 2022	BUY	$131.98 - $163.75 $3.56 Million - $4.42 Million	26,998 New	26,998 $4.38 Million
Q3 2020 Nov 13, 2020	SELL	$85.91 - $100.83 $4.19 Million - $4.92 Million	-48,768 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$73.37 - $98.18 $2.52 Million - $3.38 Million	-34,401 Reduced 41.36%	48,768 $4.79 Million
Q1 2020 May 15, 2020	SELL	$64.5 - $97.79 $3.74 Million - $5.67 Million	-57,976 Reduced 41.08%	83,169 $6.34 Million
Q4 2019 Feb 18, 2020	SELL	$72.13 - $90.25 $1.31 Million - $1.64 Million	-18,215 Reduced 11.43%	141,145 $12.5 Million
Q3 2019 Nov 14, 2019	BUY	$62.98 - $75.72 $7.73 Million - $9.29 Million	122,715 Added 334.88%	159,360 $12.1 Million
Q2 2019 Aug 14, 2019	SELL	$65.7 - $83.98 $61,101 - $78,101	-930 Reduced 2.48%	36,645 $2.67 Million
Q1 2019 May 15, 2019	BUY	$77.14 - $90.79 $46,284 - $54,474	600 Added 1.62%	37,575 $3.03 Million
Q4 2018 Feb 14, 2019	SELL	$77.85 - $96.01 $136,237 - $168,017	-1,750 Reduced 4.52%	36,975 $3.41 Million
Q3 2018 Nov 14, 2018	BUY	$88.91 - $98.84 $1.02 Million - $1.14 Million	11,500 Added 42.24%	38,725 $3.66 Million
Q2 2018 Aug 14, 2018	SELL	$89.78 - $106.23 $89,780 - $106,230	-1,000 Reduced 3.54%	27,225 $2.52 Million
Q1 2018 May 15, 2018	BUY	$92.01 - $123.21 $683,174 - $914,834	7,425 Added 35.7%	28,225 $2.67 Million
Q4 2017 Feb 14, 2018	BUY	$89.56 - $98.21 $1.51 Million - $1.66 Million	16,900 Added 433.33%	20,800 $2.01 Million
Q3 2017 Nov 14, 2017	BUY	$69.85 - $89.22 $272,415 - $347,958	3,900	3,900 $347,000

Others Institutions Holding ABBV

# of Institutions

3,778

Shares Held

1.28B

Call Options Held

13M

Put Options Held

9.82M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $357B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital International, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Capital International, Inc. with notifications on news.

Account

Capital International, Inc. Abb Vie Inc. Transaction History